Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.
Regulatory Roundup: Narcan’s Nod, an ALS Adcomm, FDA Holds Lifted & More
